Skip to main content

Formulating and Implementing Pharmaceutical Pricing Policies

Challenges, Case Studies and Lessons Learned from Medicine Price Control

  • 1st Edition - March 1, 2025
  • Editor: Zaheer Babar
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 4 4 3 - 2 3 5 1 8 - 4
  • eBook ISBN:
    9 7 8 - 0 - 4 4 3 - 2 3 5 1 9 - 1

Formulating and implementing pharmaceutical pricing policies: Challenges, case studies and lessons learned from medicine price control provides readers with a framework to unders… Read more

Formulating and Implementing Pharmaceutical Pricing Policies

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Image of books

Institutional subscription on ScienceDirect

Request a sales quote

Formulating and implementing pharmaceutical pricing policies: Challenges, case studies and lessons learned from medicine price control provides readers with a framework to understand and analyze several medicine pricing policies. Through case studies from countries across geographies and income tiers, the book explores the challenges and opportunities related to price control experiences.

Studying policies from Australia, New Zealand, China, the European Union, South Africa, India among other countries, the book discusses approaches, strategies, and the underlying pharmaceutical pricing practices used to provide advice for formulating highly effective policies. Alongside the cases, this book covers appropriate research methods for pricing analysis, the essential components of pricing policy, data quality, and the generic structure of a pharmaceutical pricing policy.

Formulating and implementing pharmaceutical pricing policies: Challenges, case studies and lessons learned from medicine price control discusses how a medicine pricing policy is formed, why they differ from country to country based on the local health system, and what results can be achieved. This book is an important reference for pharma professionals, regulatory agencies, and policy makers. Researchers investigating Pharmacoeconomics, and overall healthcare cost will also benefit from the analysis framework described in this book.